| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT04165317 | A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer | Non-muscle Invasive Bladder Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT07123090 | A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Recruiting |
| Phase 1/2 | |||
| NCT05665361 | Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma… | Advanced Clear Cell Renal Carcinoma (Ccrcc) | Recruiting |
| NCT04181788 | Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies | Advanced Malignancies | Active, Not Recruiting |
| Phase 1 | |||
| NCT07206225 | A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer | Non-muscle Invasive Bladder Cancer | Recruiting |